{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:35:35Z","timestamp":1793795735214,"version":"4.6.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000194","name":"Nova Scotia Health Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009408","name":"Fondation Brain Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.nicl.2019.102049","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T11:51:57Z","timestamp":1571745117000},"page":"102049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"special_numbering":"C","title":["Blood-brain barrier imaging as a potential biomarker for bipolar disorder progression"],"prefix":"10.1016","volume":"26","author":[{"given":"Lyna","family":"Kamintsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronel","family":"Veksler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Beyea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Calkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nicl.2019.102049_bib0001","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.nicl.2019.102049_bib0002","doi-asserted-by":"crossref","unstructured":"Hui, S., Sim, K. & Baldessarini, R. J.Pharmacological approaches for treatment-resistant bipolar disorder. 592\u2013604 (2015).","DOI":"10.2174\/1570159X13666150630171954"},{"key":"10.1016\/j.nicl.2019.102049_bib0003","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1515\/hsz-2015-0257","article-title":"Kinins and microglial responses in bipolar disorder: a neuroinflammation hypothesis","volume":"397","author":"Naaldijk","year":"2016","journal-title":"Biol. Chem."},{"key":"10.1016\/j.nicl.2019.102049_bib0004","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/708306","article-title":"Disruption in the blood-brain barrier: The missing link between brain and body inflammation in bipolar disorder","author":"Patel","year":"2015","journal-title":"Neural. Plast."},{"key":"10.1016\/j.nicl.2019.102049_bib0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nicl.2019.102049_bib0006","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nicl.2019.102049_bib0007","first-page":"262","article-title":"Neuroimage\u202f: clinical assessment of blood \u2013 brain barrier disruption using dynamic contrast-enhanced MRI . A systematic review","volume":"6","author":"Heye","year":"2014","journal-title":"YNICL"},{"key":"10.1016\/j.nicl.2019.102049_bib0008","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/RLI.0b013e31823bfc97","article-title":"Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T","volume":"47","author":"Ingrisch","year":"2012","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.nicl.2019.102049_bib0009","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.nicl.2013.12.001","article-title":"NeuroImage\u202f: clinical abnormal blood \u2013 brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI \u2606, \u2606\u2606","volume":"4","author":"Cramer","year":"2014","journal-title":"NeuroImage. Clin."},{"key":"10.1016\/j.nicl.2019.102049_bib0011","doi-asserted-by":"crossref","unstructured":"Haider, L., Naismith, R. T. & Rovira, A.Use of gadolinium for MRI diagnostic or surveillance studies in patients with MS. 239\u2013240 (2019). 10.1212\/WNL.0000000000007891.","DOI":"10.1212\/WNL.0000000000007891"},{"key":"10.1016\/j.nicl.2019.102049_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0171558","article-title":"Evolution of blood-brain-barrier permeability after acute ischemic stroke","volume":"12","author":"Merali","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.nicl.2019.102049_bib0013","doi-asserted-by":"crossref","unstructured":"Kassner, A., Roberts, T. P. L., Moran, B., Silver, F. L. & Mikulis, D. J.Increases blood-brain barrier disruption in acute ischemic stroke\u202f: an MR imaging permeability. (2009). 10.3174\/ajnr.A1774.","DOI":"10.3174\/ajnr.A1774"},{"key":"10.1016\/j.nicl.2019.102049_bib0014","doi-asserted-by":"crossref","unstructured":"Serlin, Y. et\u00a0al. Blood-brain barrier leakage in TIA. 1266\u20131269 (2019). 10.1161\/STROKEAHA.119.025247.","DOI":"10.1161\/STROKEAHA.119.025247"},{"key":"10.1016\/j.nicl.2019.102049_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/905279","article-title":"Measurement of blood-brain barrier permeability with t1-weighted dynamic contrast-enhanced MRI in brain tumors: a comparative study with two different algorithms","author":"Bergamino","year":"2013","journal-title":"ISRN Neurosci."},{"key":"10.1016\/j.nicl.2019.102049_bib0016","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/brain\/awx073","article-title":"Imaging blood\u2013brain barrier dysfunction as a biomarker for epileptogenesis","volume":"140","author":"Bar-Klein","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2019.102049_bib0017","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2014.2682","article-title":"Imaging blood-brain barrier dysfunction in football players","volume":"71","author":"Weissberg","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nicl.2019.102049_bib0018","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/jnnp.2007.126425","article-title":"Blood-brain barrier disruption in post-traumatic epilepsy","volume":"79","author":"Tomkins","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nicl.2019.102049_bib0019","article-title":"Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction","author":"Nation","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.nicl.2019.102049_bib0020","first-page":"159","article-title":"Measuring subtle leakage of the blood \u2013 brain barrier in cerebrovascular disease with DCE-MRI\u202f: test \u2013 retest reproducibility and its influencing factors","author":"Wong","year":"2017","journal-title":"et al"},{"key":"10.1016\/j.nicl.2019.102049_bib0021","doi-asserted-by":"crossref","unstructured":"Wilson, P. W. F. et\u00a0al. Prediction of coronary heart disease using risk factor categories. (1998).","DOI":"10.1161\/01.CIR.97.18.1837"},{"key":"10.1016\/j.nicl.2019.102049_bib0022","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation task force on epidemiology and prevention; national heart, lung, and blood institute; American Heart Association; World Heart Federation; International","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.nicl.2019.102049_bib0023","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1743-7075-7-26","article-title":"Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007)","volume":"7","author":"Esteghamati","year":"2010","journal-title":"Nutr. Metab. (Lond)."},{"key":"10.1016\/j.nicl.2019.102049_bib0024","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-0327(01)00451-7","article-title":"Defining remission by cut off score on the MADRS: selecting the optimal value","volume":"72","author":"Hawley","year":"2002","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.nicl.2019.102049_bib0025","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mds.23184","article-title":"Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the beck anxiety inventory, and the hospital anxiety and depression scale","volume":"26","author":"Leentjens","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nicl.2019.102049_bib0026","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0033-3182(95)71666-8","article-title":"Global assessment of functioning","volume":"36","author":"Hall","year":"1995","journal-title":"Psychosomatics"},{"key":"10.1016\/j.nicl.2019.102049_bib0010","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1113\/JP276887","article-title":"Blood\u2013brain barrier permeability measured using dynamic contrast-enhanced magnetic resonance imaging: a validation study","volume":"597","author":"Varatharaj","year":"2019","journal-title":"J. Physiol."},{"key":"10.1016\/j.nicl.2019.102049_bib0027","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.arcmed.2014.11.016","article-title":"Blood-brain barrier imaging in human neuropathologies","volume":"45","author":"Veksler","year":"2014","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.nicl.2019.102049_bib0028","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2045-8118-10-9","article-title":"Quantitative imaging assessment of blood-brain barrier permeability in humans","volume":"10","author":"Chassidim","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.nicl.2019.102049_bib0029","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.bbadis.2015.11.013","article-title":"The role of insulin in the vascular contributions to age-related dementia","volume":"1862","author":"Hughes","year":"2016","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.nicl.2019.102049_bib0030","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1586\/ern.10.185","article-title":"Insulin dysfunction and allostatic load in bipolar disorder","volume":"11","author":"Brietzke","year":"2011","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.nicl.2019.102049_bib0031","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1192\/bjp.bp.114.152850","article-title":"Insulin resistance and outcome in bipolar disorder","volume":"206","author":"Calkin","year":"2015","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.nicl.2019.102049_bib0033","first-page":"1","article-title":"Annals of Medicine Insulin resistance takes center stage\u202f: a new paradigm in the progression of bipolar disorder","volume":"0","author":"Calkin","year":"2019","journal-title":"Ann. Med."},{"key":"10.1016\/j.nicl.2019.102049_bib0034","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/wps.20309","article-title":"Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis","volume":"15","author":"Vancampfort","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1016\/j.nicl.2019.102049_bib0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pnpbp.2018.01.004","article-title":"Atypical antipsychotics, insulin resistance and weight; a meta-analysis of healthy volunteer studies","volume":"83","author":"Burghardt","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.nicl.2019.102049_bib0036","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1399-5618.2008.00625.x","article-title":"Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics","volume":"10","author":"Correll","year":"2008","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.nicl.2019.102049_bib0037","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archpsyc.1978.01770310043002","article-title":"A diagnostic interview: the schedule for affective disorders and schizophrenia","volume":"35","author":"Endicott","year":"1978","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.nicl.2019.102049_bib0038","series-title":"American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.nicl.2019.102049_bib0039","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.4088\/JCP.v69n1203","article-title":"Long-term effectiveness of lithium in bipolar disorder: a multicenter investigation of patients with typical and atypical features","volume":"69","author":"Berghofer","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.nicl.2019.102049_bib0040","doi-asserted-by":"crossref","unstructured":"Deoni, S. C. L., Peters, T. M. & Rutt, B. K. High-resolution T 1 and T 2 mapping of the brain in a clinically acceptable time with DESPOT1 and DESPOT2. 241, 237\u2013241 (2005).","DOI":"10.1002\/mrm.20314"}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158219303961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158219303961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:29:37Z","timestamp":1761971377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158219303961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":39,"alternative-id":["S2213158219303961"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2019.102049","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood-brain barrier imaging as a potential biomarker for bipolar disorder progression","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2019.102049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102049"}}